[Resistance to hycanthone and oxamniquine in patients with a clinical hepato-intestinal form of schistosomiasis].
D000328:Adult; D000818:Animals; D004351:Drug Resistance; D005260:Female; D006801:Humans; D006826:Hycanthone / Q000627:therapeutic use*; D007411:Intestinal Diseases, Parasitic / Q000188:drug therapy*; D008109:Liver Diseases, Parasitic / Q000188:drug therapy*; D008297:Male; D051379:Mice; D009600:Nitroquinolines / Q000627:therapeutic use*; D010073:Oxamniquine / Q000627:therapeutic use*; D012552:Schistosomiasis / Q000175:diagnosis / Q000188:drug therapy*; D013892:Thioxanthenes / Q000627:therapeutic use*
D009600:Nitroquinolines; D013892:Thioxanthenes; D010073:Oxamniquine; D006826:Hycanthone
Resistência ao hycanthone e oxamniquine em doentes com esquistossomose forma clínica hepatintestinal.